Immunobel-Pro®
Immunobel-Pro® is a dietary supplement exclusive to healthcare professionals. It is made out of a select preparation of purified Escherichia Coli K-12 RNA fragments to help maintain healthy platelet and white blood cell counts.* Immunobel-Pro® is sold exclusively to healthcare professionals who want to provide their patients with the highest quality dietary supplements.*
Note: OnKobel-Pro® & Immunobel-Pro® cannot be sold on third party websites and should only be administered to clients after they receive protocols from a healthcare professional. Click here for our Professional Terms & Conditions for full details.
Product Details
Dr. Mirko Beljanski researched natural extracts that would help strengthen the immune system. This led him to create a breakthrough product to support the production of platelets and white blood cells—which are both crucial for healthy blood clotting and immunity.* DNA duplication requires small RNA fragments that function as primers for DNA synthesis. Dr. Beljanski realized that a shortage of these RNA primers in bone marrow stem cells could be a primary cause of neutropenia (low white blood cell counts) and thrombocytopenia (low platelet counts). After coming to this conclusion, Dr. Beljanski prepared short fragments of RNA that are specific to bone marrow DNA, and studied their ability to stimulate the proliferation of white blood cells and platelets.*1,2
A clinical trial conducted at Cancer Treatment Centers of America showed that the RNA fragments helped maintain healthy platelet counts, even in a population of patients undergoing chemotherapy (In this study, no patient developed either neutropenia or thrombocytopenia).*3
Immunobel-Pro® contains 40 mg of RNA fragments prepared according to Dr. Beljanski’s exclusive methodology and are available to healthcare professionals for their patients. The RNA fragments naturally support healthy levels of platelets and white blood cells without any reported negative side effects.*
Content: 10 doses
Suggested Use: As a dietary supplement, take 1 dose every 3 or 4 days, or as recommended by a healthcare practitioner. This dosage may be adjusted depending on white blood cell and platelet counts results. Avoid food and drinking water a minimum of 20 minutes before and after taking Immunobel-Pro®. Do not exceed the recommended daily dosage.
Recommendations: Keep out of reach of children. Consult a healthcare practitioner before use if you are pregnant, nursing, have a medical condition or are taking any prescription medication. Our formulation does not contain any known allergens. However, while our Manufacturers take steps to minimize the risk of any cross contact, we cannot guarantee that any of our products do not contain trace amounts of, and are safe for consumers with peanut, tree nut, soy, milk, egg, shellfish or wheat allergies. The use of Immunobel-Pro® is not recommended for people following a treatment with Benzodiazepine or when an aplasia is sought in the case of certain cancer treatments. Regular intake of magnesium is recommended.
References:
1. Beljanski M, Plawecki M, Bourgarel P, Beljanski MS. Nouvelles substances (R.L.B.) actives dans la leucopoïèse et la formation des plaquettes. Bull. Acad. Nat. Méd. 1978;(162)6:475-781.
2. Beljanski M. Overview: BLRs as Inducers of In Vivo Leucocyte and Platelet Genesis. Deutsche Zeitschrift für Onkologie. 1992(24)2:41-46.
3. Levin RD, Daehler M, Grutsch Jf, Hall JL, Gupta D, et al. Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. BMC Cancer. 2010;10:565.
Benefits
Our Story Behind The Product
Unique Composition
Immunobel-Pro® is composed of special RNA primers that interact with nascent DNA strands to enhance replication of the DNA. Dr. Mirko Beljanski found a way to produce large quantities of these RNA primers, using Escherichia coli K12, a nonpathogenic strain naturally present in the human intestine.*
A Scientific Breakthrough
While RNA fragments have long been identified as “Essential Nutrients,”1 Mirko Beljanski‘s patented technology allowed him to show, in animal studies, that these RNA primers are able to drastically increase the production of normal white blood cells and megakaryocytes, which leads to the production of platelets.2 This discovery showed that the critical role of RNA fragments in DNA duplication is clinically relevant in hematopoiesis, specifically for neutropenia and thrombocytopenia. Incidentally, this discovery was also an important advance in our understanding of biology because white blood cells and megakaryocytes are at the core of our immune system.*
1. G.K. Krimble, “Essential and Conditionally-Essential Nutrients in Clinical Nutrition”. Nutrition Research Reviews, (1993) 6, 97-119.
2. Beljanski M, Plawecki M. Particular RNA fragments as promoter of leucocyte and platelet formation in rabbits. Exp Cell Biol. 1979;47:218–225.
Clinical Research
A clinical trial conducted at the Cancer Treatment Centers of America confirmed that RNA fragments helped maintain healthy platelet and white blood cell levels even in a population suffering from low-platelet counts. The clinical trial also confirmed that the product has a great safety profile, and is well tolerated. None of the patients enrolled in the clinical trial had to interrupt their conventional treatment or required platelet transfusion.3 Other sources of RNA fragments (from yeast) were compared and did not present the same benefits as E. Coli K12 RNA fragments.
3. Levin RD, Daehler M, Grutsch JF, Hall JL, Gupta D, et al. Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. BMC Cancer. 2010;10:565.
Easy, Safe & Consistent Results*
The monitoring of platelet counts reveals that Immunobel-Pro® delivers results in 24 to 48 hours. It is an easy to handle, easy to swallow, pleasant tasting white powder. Each dose contains 40 mg of Beljanski’s exclusive ribonucleic acid extract of Escherichia Coli K-12. Each dose delivers results safely and consistently.*
RNA fragments from E.Coli K12 were notified to the FDA as a new Dietary Ingredient in 1997.
